Raymond James Financial Inc. purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 705,164 shares of the medical device company's stock, valued at approximately $64,826,000. Raymond James Financial Inc. owned about 0.35% of Cooper Companies as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Arizona State Retirement System raised its holdings in shares of Cooper Companies by 1.3% in the fourth quarter. Arizona State Retirement System now owns 57,817 shares of the medical device company's stock worth $5,315,000 after acquiring an additional 769 shares during the last quarter. Proficio Capital Partners LLC purchased a new stake in Cooper Companies during the 4th quarter worth about $95,000. Victory Capital Management Inc. raised its stake in Cooper Companies by 14.6% in the 4th quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after purchasing an additional 574,899 shares during the last quarter. Torray Investment Partners LLC raised its stake in Cooper Companies by 0.8% in the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after purchasing an additional 132 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Cooper Companies by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,151,654 shares of the medical device company's stock valued at $105,872,000 after purchasing an additional 35,035 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
COO has been the subject of a number of analyst reports. Morgan Stanley cut their price objective on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Friday, December 6th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Piper Sandler reissued an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. JPMorgan Chase & Co. reduced their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Finally, Robert W. Baird dropped their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Three research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies currently has a consensus rating of "Moderate Buy" and an average price target of $111.89.
Get Our Latest Stock Analysis on Cooper Companies
Cooper Companies Trading Up 4.5 %
NASDAQ COO traded up $3.49 during mid-day trading on Friday, hitting $81.22. The company's stock had a trading volume of 2,436,699 shares, compared to its average volume of 1,255,824. The firm has a market capitalization of $16.21 billion, a P/E ratio of 41.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 52-week low of $76.46 and a 52-week high of $112.38. The stock's fifty day simple moving average is $91.67 and its two-hundred day simple moving average is $99.11.
Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
Cooper Companies Profile
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
